PMID- 33269683
OWN - NLM
STAT- MEDLINE
DCOM- 20220201
LR  - 20240330
IS  - 1476-1645 (Electronic)
IS  - 0002-9637 (Print)
IS  - 0002-9637 (Linking)
VI  - 104
IP  - 2
DP  - 2020 Dec 2
TI  - COVID-19 and Tuberculosis-Related Catastrophic Costs.
PG  - 436-440
LID - tpmd201125 [pii]
LID - 10.4269/ajtmh.20-1125 [doi]
AB  - The COVID-19 pandemic has created an unprecedented health crisis and a 
      substantial socioeconomic impact. It also affects tuberculosis (TB) control 
      severely worldwide. Interruptions of many TB control programs because of the 
      COVID-19 pandemic could result in significant setbacks. One of the targets that 
      can be affected is the WHO's End TB Strategy goal to eliminate catastrophic costs 
      of TB-affected households by 2030. Disruptions to TB programs and healthcare 
      services due to COVID-19 could potentially prolong diagnostic delays and worsen 
      TB treatment adherence and outcomes. The economic recession caused by the 
      pandemic could significantly impact household financial capacity because of the 
      reduction of income and the rise in unemployment rates. All of these factors 
      increase the risk of TB incidence and the gravity of economic impact on 
      TB-affected households, and hamper efforts to eliminate catastrophic costs and 
      control TB. Therefore, efforts to eliminate the incidence of TB-affected 
      households facing catastrophic costs will be very challenging. Because financial 
      constraint plays a significant role in TB control, the improvement of health and 
      social protection systems is critical. Even before the pandemic, many 
      TB-high-burden countries (HBCs) lacked robust health and social protection 
      systems. These challenges highlight the substantial need for a more robust 
      engagement of patients and civil society organizations and international support 
      in addressing the consequences of COVID-19 on the control of TB.
FAU - Fuady, Ahmad
AU  - Fuady A
AD  - 1Department of Public Health, Erasmus MC, University Medical Center Rotterdam, 
      Rotterdam, The Netherlands.
AD  - 2Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, 
      Jakarta, Indonesia.
FAU - Houweling, Tanja A J
AU  - Houweling TAJ
AD  - 1Department of Public Health, Erasmus MC, University Medical Center Rotterdam, 
      Rotterdam, The Netherlands.
FAU - Richardus, Jan Hendrik
AU  - Richardus JH
AD  - 1Department of Public Health, Erasmus MC, University Medical Center Rotterdam, 
      Rotterdam, The Netherlands.
LA  - eng
PT  - Journal Article
DEP - 20201202
PL  - United States
TA  - Am J Trop Med Hyg
JT  - The American journal of tropical medicine and hygiene
JID - 0370507
SB  - IM
CIN - Am J Trop Med Hyg. 2021 Jan 06;104(2):407-409. PMID: 33410391
MH  - COVID-19/*economics/epidemiology
MH  - Family Characteristics
MH  - Health Care Costs/standards/*statistics & numerical data/trends
MH  - Humans
MH  - Incidence
MH  - Income
MH  - SARS-CoV-2
MH  - Tuberculosis/*economics/epidemiology/prevention & control
PMC - PMC7866313
EDAT- 2020/12/04 06:00
MHDA- 2022/02/02 06:00
PMCR- 2020/12/02
CRDT- 2020/12/03 08:34
PHST- 2020/09/02 00:00 [received]
PHST- 2020/11/23 00:00 [accepted]
PHST- 2020/12/04 06:00 [pubmed]
PHST- 2022/02/02 06:00 [medline]
PHST- 2020/12/03 08:34 [entrez]
PHST- 2020/12/02 00:00 [pmc-release]
AID - tpmd201125 [pii]
AID - 10.4269/ajtmh.20-1125 [doi]
PST - epublish
SO  - Am J Trop Med Hyg. 2020 Dec 2;104(2):436-440. doi: 10.4269/ajtmh.20-1125.